CAFARO, Giacomo
 Distribuzione geografica
Continente #
NA - Nord America 716
EU - Europa 521
AS - Asia 263
SA - Sud America 3
Totale 1.503
Nazione #
US - Stati Uniti d'America 710
IE - Irlanda 234
IT - Italia 113
HK - Hong Kong 90
SG - Singapore 76
VN - Vietnam 72
FR - Francia 42
SE - Svezia 40
RU - Federazione Russa 24
FI - Finlandia 17
DE - Germania 15
CN - Cina 14
CH - Svizzera 12
UA - Ucraina 10
CA - Canada 5
JP - Giappone 5
GB - Regno Unito 4
AT - Austria 2
BR - Brasile 2
ES - Italia 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
NL - Olanda 2
UZ - Uzbekistan 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
MX - Messico 1
PL - Polonia 1
Totale 1.503
Città #
Dublin 231
Chandler 176
Hong Kong 89
San Mateo 89
Dong Ket 70
Altamura 50
Singapore 43
Lawrence 40
Medford 40
Princeton 40
Wilmington 33
Falls Church 16
Perugia 15
Los Angeles 14
Andover 13
New York 13
San Paolo di Civitate 13
Saint Petersburg 11
Des Moines 9
Helsinki 7
Norwalk 7
Beijing 6
Ashburn 5
Menlo Park 5
Redmond 5
Redwood City 5
Frankfurt Am Main 4
Lappeenranta 4
Florence 3
Mainz 3
Montréal 3
Shanghai 3
Arezzo 2
Den Haag 2
Fairfield 2
Frosinone 2
Hanoi 2
Jacksonville 2
Kingston 2
Mataró 2
Milan 2
Palermo 2
Santarcangelo di Romagna 2
Stockport 2
São Paulo 2
Tel Aviv 2
Vienna 2
Woodbridge 2
Acerra 1
Ann Arbor 1
Brno 1
Cambridge 1
Castelvetrano 1
Catanzaro 1
Central District 1
Chengdu 1
Chicago 1
Desio 1
Esslingen am Neckar 1
Frankfurt am Main 1
Gualtieri 1
Houston 1
Lausanne 1
Morioka 1
Moscow 1
Nanjing 1
Paris 1
Philadelphia 1
Quito 1
Rheinfelden 1
Rome 1
Spoleto 1
Tokyo 1
Totale 1.122
Nome #
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 73
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 56
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 54
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 49
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 47
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 47
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 46
A Platelet's Guide to Synovitis 45
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? 44
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 43
BCL2-associated athanogene 3 protein is associated with B-cell hyperactivity including lymphoma in primary sjÖgren's syndrome 42
Effect of Sinovial High-Low® injections in trapeziometacarpal osteoarthritis 42
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? 41
One year in review 2019: Sjögren's syndrome 39
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 37
Drugs in induction and treatment of idiopathic inflammatory myopathies. 36
Extra-articular rheumatoid arthritis 34
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome 33
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 33
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project 33
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 33
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 33
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 32
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome 31
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 30
Central Hemodynamics and Arterial Stiffness in Systemic Sclerosis 28
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases 28
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 27
Cardiovascular Involvement in Sjögren's Syndrome 26
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 25
The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response? 25
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 24
The onset site of rheumatoid arthritis: The joints or the lung? 24
Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome 24
Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren's syndrome: an inter-system reproducibility study 22
Platelets: a potential target for rheumatoid arthritis treatment? 22
One year in review 2018: Sjogren's syndrome. 22
One year in review 2016: Sjögren's syndrome 21
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 21
Cardiovascular risk in systemic autoimmune diseases 20
Subclinical atherosclerosis in primary Sjögren's syndrome: Does inflammation matter? 20
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 20
The clinical spectrum of primary sjogren's syndrome: Beyond exocrine glands 19
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 19
Sjögren's syndrome: one year in review 2022 18
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 16
Comment on: "Gluten or no gluten for rheumatic diseases?‿ by Philippou E et al. 13
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis 11
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 11
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon 10
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 9
Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease 8
Psoriatic arthritis: tissue-directed inflammation? 8
Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren's Syndrome 8
One year in review 2021: Sjögren's syndrome 7
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters 6
Microbiota and arthritis: cause or consequence? 6
Cardiovascular risk in patients with Sjögren's syndrome: is it time for a new approach? 6
Primary Sjögren's syndrome in Italy: Real-world evidence of a rare disease through administrative healthcare data 5
Microbiota and arthritis: cause or consequence? 5
Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art 2
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint 2
Primary Sjögren's syndrome in Italy: Real-world evidence of a rare disease through administrative healthcare data 2
Totale 1.623
Categoria #
all - tutte 8.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 2 7 4 0 0 0 5 9 4 9 4 0
2020/2021192 3 0 3 14 69 7 9 5 5 3 3 71
2021/2022314 3 61 4 9 23 12 4 72 7 12 56 51
2022/2023660 41 133 7 56 59 55 2 23 245 1 31 7
2023/2024357 21 40 8 21 5 37 80 4 29 14 51 47
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.623